中文名 | CP21R7 |
英文名 | CP21R7 |
别名 | 化合物CP21R7 GSK-3Β抑制剂(CP21R7) 3-(3-氨基苯基)-4-(1-甲基-1H-吲哚-3-基)吡咯-2,5-二酮 3-(3-氨基苯基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 |
英文别名 | CP21R7 CS-2352 CP21R7(CP21) CP21 (CP21R7) 3-(3-Aminophenyl)-4-(1-methyl-1H-indol-3-yl)pyrrole-2,5-dione 3-(3-aminophenyl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione 3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione 1H-Pyrrole-2,5-dione, 3-(3-aminophenyl)-4-(1-methyl-1H-indol-3-yl)- |
CAS | 125314-13-8 |
化学式 | C19H15N3O2 |
分子量 | 317.34 |
密度 | 1.37±0.1 g/cm3(Predicted) |
沸点 | 627.4±55.0 °C(Predicted) |
溶解度 | DMSO: ≥ 32 mg/mL |
酸度系数 | 7.79±0.60(Predicted) |
存储条件 | Keep in dark place,Inert atmosphere,Store in freezer, under -20°C |
体外研究 | CP21R7 (Compound 9) is a selective inhibitor of GSK-3β, with an IC 50 of 1.8 nM; the IC 50 of CP21R7 against PKCα is 1900 nM. CP21R7 (CP21, 3 μM) potently activates canonical Wnt signaling with highest activity. CP21 significantly increases total levels of intracellular β-catenin. CP21 combined with BMP4 induces commitment of hPSCs towards mesoderm. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.151 ml | 15.756 ml | 31.512 ml |
5 mM | 0.63 ml | 3.151 ml | 6.302 ml |
10 mM | 0.315 ml | 1.576 ml | 3.151 ml |
5 mM | 0.063 ml | 0.315 ml | 0.63 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!